Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cyclosporine A.
Two patients with severe arthralgia associated with palmoplantar pustulosis (PPP) were treated with oral cyclosporine A (CsA). Clinical efficacy was assessed on a 0-4 point scale for erythema, desquamation, infiltration, and pustulation, and on a 0-3 point pain scale. Skin lesions and arthralgia improved within twelve weeks with low dose CsA ranging from 2.1 to 2.2 mg/kg/day. High levels of plasma interleukin-6 (IL-6) were reduced to the normal range.
Yamamoto
T
T
Department of Dermatology, Tokyo Medical and Dental University School of Medicine, Japan.
Kimura
K
K
Katayama
I
I
Nishioka
K
K
D000284:Administration, Oral; D000328:Adult; D018771:Arthralgia / Q000209:etiology*; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy; D016572:Cyclosporine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D016572:Cyclosporine